Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Back

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2009
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironmentJonathan M Weiss, Timothy C Back, Anthony J Scarzello, et al.
Nature Medicine|March 6, 2007
IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapyVanessa Berner, Haiyan Liu, Qing Zhou, et al.
Cancer Research|September 23, 2003
Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL geneWenbin Ma, Lino Tessarollo, Seung-Beom Hong, et al.
Cancer Investigation|May 11, 2012
High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discoveryJimmy K Stauffer, Rimas J Orentas, Erin Lincoln, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrowRosalba Salcedo, Julie A Hixon, Jimmy K Stauffer, et al.
International Journal of Cancer|July 24, 2012
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinomaNaotake Funamizu, Chaoxin Hu, Curtis Lacy, et al.
Cancer Research|April 10, 2021
Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET ProteinsPoonam Tewary, Alan D Brooks, Ya-Ming Xu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2009
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironmentJonathan M Weiss, Timothy C Back, Anthony J Scarzello, et al.
Nature Medicine|March 6, 2007
IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapyVanessa Berner, Haiyan Liu, Qing Zhou, et al.
Cancer Research|September 23, 2003
Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL geneWenbin Ma, Lino Tessarollo, Seung-Beom Hong, et al.
Cancer Investigation|May 11, 2012
High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discoveryJimmy K Stauffer, Rimas J Orentas, Erin Lincoln, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrowRosalba Salcedo, Julie A Hixon, Jimmy K Stauffer, et al.
International Journal of Cancer|July 24, 2012
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinomaNaotake Funamizu, Chaoxin Hu, Curtis Lacy, et al.
Cancer Research|April 10, 2021
Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET ProteinsPoonam Tewary, Alan D Brooks, Ya-Ming Xu, et al.
Pageof 2